Global_ GS Economic Indicators Update_ Positive Growth News in the Euro Area, Negative in the US
2025-03-14 04:56
10 March 2025 | 3:53PM EDT Global: GS Economic Indicators Update: Positive Growth News in the Euro Area, Negative in the US Please find an update of our proprietary global economic indicators below. The data behind these exhibits can be downloaded here. Interactive charts can be found on our living page here. Chart of the Week -4 -3 -2 -1 0 1 2 3 4 -4 -3 -2 -1 0 1 2 3 4 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Index Index US Euro Area GS MAP Surprise Index (21 Day MA) Our daily MAP surprise i ...
Commodities Dashboard_ Curve Structure, Volatility, Momentum and Positioning data – Mar 10 update
2025-03-14 04:56
V i e w p o i n t | 11 Mar 2025 02:50:00 ET │ 13 pages Commodities Dashboard Curve Structure, Volatility, Momentum and Positioning data – Mar 10 update CITI'S TAKE This is our new Commodities Dashboard which replaces our legacy Commodities Flows Chartpack and Commodities Volatility Dashboard and provides the latest curve structure, volatility, momentum and positioning data across major commodity markets. Our Backwardation Dashboard (see Figure 1) shows HH natgas and ICE coffee as the most backwardated commo ...
China Healthcare_ Trip takeaways_ Medtech bottoming out, gradual recovery in 2025; eyes on equipment VBP
2025-03-14 04:56
11 March 2025 | 7:41AM CST China Healthcare: Trip takeaways: Medtech bottoming out, gradual recovery in 2025; eyes on equipment VBP We recently (Feb 24-28, 2025) hosted an investor field trip with several Chinese Healthcare companies. The discussions mainly focused on industry growth outlook and VBP impact. We believe China MedTech is likely bottoming-out with potential regional VBP risks around medical equipment, and see recovery starting in 2025. In this note, we discuss takeaways from meeting with our co ...
Global Healthcare_ Takeaways from Inaugural MedTech & Tools China Trip; Consumer and CapEx Markets an Inflection
2025-03-14 04:56
10 March 2025 | 5:31PM PDT Global Healthcare Takeaways from Inaugural MedTech & Tools China Trip; Consumer and CapEx Markets an Inflection We recently hosted an investor field trip to China to gain an on-the-ground pulse for market and competitive dynamics in MedTech, Lifescience Tools, Diagnostics, and CRO/CDMOs. During our visit, we met with locally-domiciled companies, market data and policy experts, physicians, venture capitalists, emerging growth companies, and the GS Economics team. Amidst ongoing pol ...
Americas Technology_ Internet_ Q4'24 EPS Review_ Where To From Here_ Recapping Takeaways & Debates; Focus Stocks Going Forward
2025-03-14 04:56
10 March 2025 | 5:43PM EDT Americas Technology: Internet Q4'24 EPS Review: Where To From Here? Recapping Takeaways & Debates; Focus Stocks Going Forward During this past earnings season, US Consumer Internet & Interactive Entertainment companies delivered a volatile array of stock price reactions as global investors grappled with three key themes/debates: 1) the rate of investment in AI by the largest companies under our coverage continued to increase (especially for those with foundational model and/or hyp ...
China Healthcare_ Medical Devices_ Accelerating VBP expansion; focus on targets for next round, with direction likely to remain consistent
2025-03-14 04:56
11 March 2025 | 8:24AM HKT China Healthcare: Medical Devices Accelerating VBP expansion; focus on targets for next round, with direction likely to remain consistent In this report, we summarize results & impacts from VBPs for key products over the past years, and our outlook for VBP policy impact from 2025 onwards. Accelerating expansion into broader products through national & regional alliances: With the 1st national round initiated in 2020 on drug-eluting stent, VBP has now extended to majority of the pr ...
The 720_ Global Views, MediaTek, BEKE, Coupang, China Spirits, US Internet
2025-03-14 04:56
11 March 2025 | 7:17AM HKT The 720: Global Views, MediaTek, BEKE, Coupang, China Spirits, US Internet In Focus | Global Views Global Views - From Above to Below. We have downgraded our 2025 US GDP growth forecast from 2.4% at the start of the year to 1.7% now (both on a Q4/Q4 basis). This is our first below-consensus forecast in 2½ years. The main reason for the downgrade is not the recent data, as the February jobs report was decent, initial jobless claims are still low, the February ISMs—as well as our br ...
China Beauty Products_ 3.8 Results – Proya Retains No. 1 Rank; Giant Biogene Gains Share
2025-03-14 04:56
March 11, 2025 12:54 AM GMT Overall, we think this is a positive result. And, if Proya can demonstrate OPM improvement for its 1Q25 earnings, we think its stock could start gaining more attention. Proya Cosmetics: Meeting Takeaways - Global Top 10 In 10 Years (28 Feb 2025) Proya Cosmetics: Risk Reward Update (25 Feb 2025) Giant Biogene (2367.HK): Comfy's momentum continues to be strong, ranked No.8 on Tmall this time, compared to No.11-13 during the big online promotions last year. Its Douyin ranking increa ...
Jefferies-AI Series 4 Power of RL and AI Agent Industry Discussion
2025-03-10 06:17
Summary of Key Points from the Conference Call Industry Overview - The conference call discusses the **Internet industry in China**, focusing on advancements in **AI technology** and the competitive landscape among major players like **Alibaba Cloud** and **Tencent** [1][4]. Core Insights - **Alibaba Cloud** launched the **QwQ-32B model** on March 6, which utilizes **reinforcement learning (RL)** to enhance reasoning capabilities, outperforming traditional training methods. The model is comparable to leading models like **DeepSeek-R1**, which has **671 billion parameters** [2]. - The **Manus AI agent**, developed by **Butterfly Effect**, has gained significant attention for its autonomous capabilities and multi-agent system powered by models such as **Claude**, **DeepSeek**, and **GPT-4**. Manus has received **State of the Art (SOTA)** recognition from **GAIA** [3]. - **Tencent** is positioned to become a **Super AI Agent** through its platform **Weixin**, leveraging its vast user base and integration of AI strategies. The upcoming conference call on **March 19** will focus on AI and cloud capital expenditures, monetization models, and user feedback on product integration [4]. Financial Projections and Capital Expenditure - **Alibaba** plans to invest over **RMB 380 billion** (approximately **$54 billion**) in AI and cloud capital expenditures over the next three years, averaging over **RMB 127 billion** (around **$18 billion**) per year. This aligns with market expectations for rapid growth in the AI sector [4]. - **Tencent** is expected to spend about **RMB 100 billion** (approximately **$14 billion**) in 2025 on AI and cloud initiatives, which is less than its competitors like Alibaba and ByteDance [4]. Market Valuation - The valuation of the **Chinese internet sector** is considered **undemanding**, trading at a discount compared to **US peers**. The anticipated growth in AI is expected to initiate a new market cycle, with recent earnings from major companies meeting or exceeding expectations [5]. Additional Insights - The call highlights the importance of **user feedback** on product integration with dual large models **Hunyuan** and **DeepSeek**, as well as the opportunities and challenges presented by AI agents [4]. - The overall sentiment in the industry is optimistic, with expectations for significant advancements and investments in AI technology, which could reshape the competitive landscape in the coming years [1][4].
Jefferies-Blaynes Bytes AVGOMRVL EPS Recap NVDA CoWoS ONALGM MC
2025-03-10 06:17
Summary of Key Points from the Conference Call Industry Overview - **Industry**: Semiconductors - **Date**: March 7, 2025 Company-Specific Insights Broadcom (AVGO) - **Market Opportunity**: AVGO reiterated a Serviceable Available Market (SAM) of $60-90 billion by FY27, indicating strong growth potential in the semiconductor space [2][2] - **Customer Engagements**: Announced two new hyperscale customer engagements, enhancing their market position [2][2] - **AI Sales Growth**: AI Networking contributed significantly, accounting for 40% of AI sales, showcasing the company's strong performance in AI-related products [2][2] - **Export Restrictions**: Management noted no current impact from export restrictions, contrasting with reports of a canceled chip order from ByteDance [2][2] Marvell Technology Group Ltd. (MRVL) - **Earnings Performance**: MRVL's stock fell approximately 20% following disappointing earnings and guidance, particularly regarding Trainium2 volumes [3][3] - **ASP Adjustments**: Average Selling Price (ASP) was lowered to $2,000, reflecting challenges in unit shipments [3][3] - **Positive Outlook**: Despite short-term challenges, management expressed optimism about their relationship with Amazon and future generations of Trainium [3][3] - **Optical Momentum**: Continued growth in optical products, particularly in 800G and 1.6T segments [3][3] NVIDIA Corporation (NVDA) - **Demand Outlook**: Fubon lowered NVDA's CoWoS demand expectations for 2025 due to demand and production issues, with Q1 production dropping to 400-500k from 700k in Q4 [4][4] - **Product Shift**: Noted a shift from air-filled racks to liquid-cooled solutions, impacting demand for certain products [4][4] - **Strong Blackwell Demand**: Despite the overall outlook, demand for Blackwell remains robust, with no cancellations from customers [4][4] ON Semiconductor Corporation (ON) - **Acquisition Proposal**: ON's acquisition proposal for Allegro MicroSystems (ALGM) was rejected, offering a 57% premium at $35.10 per share [5][5] - **Strategic Rationale**: The acquisition aimed to strengthen ON's portfolio in Autos and Industrials, with minimal product overlap [5][5] - **Financial Implications**: The transaction is expected to be gross margin accretive immediately, with EPS accretion anticipated by 2027 [7][7] Microchip Technology Inc. (MCHP) - **Business Update**: MCHP reported improved booking trends in January and February, with operational expenses decreasing [8][8] - **Cost Savings**: Expected annualized savings of $100 million, with partial realization in the June quarter [8][8] - **Cyclical Recovery**: MCHP is viewed as a cyclical recovery play, currently operating at 50% below normalized run rates [8][8] Additional Insights - **Market Sentiment**: The semiconductor industry is experiencing volatility, with companies like AVGO and MCHP positioned for growth despite challenges faced by others like MRVL and NVDA [2][3][4][8] - **Investment Recommendations**: Companies mentioned in the report include AVGO, MRVL, NVDA, ON, and MCHP, with varying outlooks based on their recent performance and market conditions [31][31] This summary encapsulates the key points from the conference call, highlighting the performance and outlook of major players in the semiconductor industry.